Close Menu

NEW YORK (GenomeWeb) – The University of California, the University of Vienna, and researcher Emmanuelle Charpentier have announced a large cross-licensing agreement for intellectual property covering CRISPR/Cas9 genome editing technology and have teamed up to defend what they view as the foundational IP for CRISPR.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Atlantic reports another SARS-CoV-2 testing problem may be lurking: backlogs.

The US Biomedical Advanced Research and Development Authority is supporting efforts to develop vaccines against SARS-CoV-2.

Researchers have sequenced the genome of "the Methuselah of freshwater fish."

In Genome Biology this week: difference in methylation in neurons from Parkinson's disease patients, differential expression analysis by barcoded sequencing approach, and more.